{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:10:06Z","timestamp":1791144606305,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s13277-015-3445-8","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T02:19:03Z","timestamp":1429496343000},"page":"7277-7283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL"],"prefix":"10.1007","volume":"36","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"issue":"6","key":"3445_CR1","doi-asserted-by":"crossref","first-page":"e100165","DOI":"10.1371\/journal.pone.0100165","volume":"9","author":"J Brouwer-Visser","year":"2014","unstructured":"Brouwer-Visser J, Lee J, McCullagh K, Cossio MJ, Wang Y, Huang GS. Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer. PLoS One. 2014;9(6):e100165.","journal-title":"PLoS One"},{"key":"3445_CR2","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","volume":"14","author":"EJ Nam","year":"2008","unstructured":"Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14:2690\u20135.","journal-title":"Clin Cancer Res"},{"key":"3445_CR3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3322\/caac.20113","volume":"61","author":"D Jelovac","year":"2011","unstructured":"Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61:183\u2013203.","journal-title":"CA Cancer J Clin"},{"key":"3445_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","volume":"13","author":"AE Pasquinelli","year":"2012","unstructured":"Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13:271\u201382.","journal-title":"Nat Rev Genet"},{"key":"3445_CR5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(03)00428-8","volume":"113","author":"V Ambros","year":"2003","unstructured":"Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003;113:673\u20136.","journal-title":"Cell"},{"key":"3445_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"issue":"3","key":"3445_CR7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cellsig.2014.12.003","volume":"27","author":"X Wang","year":"2015","unstructured":"Wang X, Li J, Dong K, Lin F, Long M, Ouyang Y, et al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal. 2015;27(3):443\u201352.","journal-title":"Cell Signal"},{"issue":"1","key":"3445_CR8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.18632\/oncotarget.2690","volume":"6","author":"WY Chen","year":"2015","unstructured":"Chen WY, Liu SY, Chang YS, Yin JJ, Yeh HL, Mouhieddine TH, et al. MicroRNA-34a regulates WNT\/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget. 2015;6(1):441\u201357.","journal-title":"Oncotarget"},{"issue":"11","key":"3445_CR9","volume":"9","author":"X Xiao","year":"2014","unstructured":"Xiao X, Chen B, Liu X, Liu P, Zheng G, Ye F, et al. Diallyl disulfide suppresses SRC\/Ras\/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a. PLoS One. 2014;9(11), e112720.","journal-title":"PLoS One"},{"issue":"1","key":"3445_CR10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3892\/mmr.2014.2726","volume":"11","author":"X Li","year":"2015","unstructured":"Li X, Zhao H, Zhou X, Song L. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil. Mol Med Rep. 2015;11(1):577\u201382.","journal-title":"Mol Med Rep"},{"issue":"2","key":"3445_CR11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.canlet.2014.08.031","volume":"354","author":"MY Wu","year":"2014","unstructured":"Wu MY, Fu J, Xiao X, Wu J, Wu RC. MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer. Cancer Lett. 2014;354(2):311\u20139.","journal-title":"Cancer Lett"},{"issue":"3","key":"3445_CR12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3892\/ijo.2014.2808","volume":"46","author":"YA Suh","year":"2015","unstructured":"Suh YA, Jo SY, Lee HY, Lee C. Inhibition of IL-6\/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells. Int J Oncol. 2015;46(3):1405\u201311.","journal-title":"Int J Oncol"},{"key":"3445_CR13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002797","volume":"8","author":"CP Concepcion","year":"2012","unstructured":"Concepcion CP, Han Y-C, Mu P, Bonetti C, Yao E, D\u2019andrea A, et al. Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet. 2012;8, e1002797.","journal-title":"PLoS Genet"},{"key":"3445_CR14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10810","volume":"482","author":"N Liu","year":"2012","unstructured":"Liu N, Landreh M, Cao K, Abe M, Hendriks G-J, Kennerdell JR, et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature. 2012;482:519\u201323.","journal-title":"Nature"},{"key":"3445_CR15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.4161\/cc.6.13.4436","volume":"6","author":"V Tarasov","year":"2007","unstructured":"Tarasov V, Jung P, Verdoodt B, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle. 2007;6:1586\u201393.","journal-title":"Cell Cycle"},{"key":"3445_CR16","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","volume":"17","author":"GT Bommer","year":"2007","unstructured":"Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol. 2007;17:1298\u2013307.","journal-title":"Curr Biol"},{"key":"3445_CR17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","volume":"26","author":"N Raver-Shapira","year":"2007","unstructured":"Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007;26:731\u201343.","journal-title":"Mol Cell"},{"key":"3445_CR18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bjc.6605505","volume":"102","author":"HH Cheung","year":"2010","unstructured":"Cheung HH, Lee TL, Davis AJ, Taft DH, Rennert OM, Chan WY. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer. Br J Cancer. 2010;102:419\u201327.","journal-title":"Br J Cancer"},{"key":"3445_CR19","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-08-0325","volume":"68","author":"M Toyota","year":"2008","unstructured":"Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, et al. Epigenetic silencing of microRNA-34b\/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008;68:4123\u201332.","journal-title":"Cancer Res"},{"key":"3445_CR20","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1038\/onc.2011.13","volume":"30","author":"G Mudduluru","year":"2011","unstructured":"Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti GV, Papotti M, Allgayer H. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a\/b in solid cancer. Oncogene. 2011;30:2888\u201399.","journal-title":"Oncogene"},{"key":"3445_CR21","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1111\/j.1742-4658.2006.05529.x","volume":"273","author":"S Hafizi","year":"2006","unstructured":"Hafizi S, Dahlback B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J. 2006;273:5231\u201344.","journal-title":"FEBS J"}],"updated-by":[{"DOI":"10.1007\/s13277-017-5487-6","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"record-id":"7251"},{"DOI":"10.1007\/s13277-017-5487-6","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000}}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3445-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3445-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T16:01:53Z","timestamp":1566576113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3445-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["3445"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3445-8","relation":{"retraction":[{"id-type":"doi","id":"10.1007\/s13277-017-5487-6","asserted-by":"object"}]},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]}}}